Impairment of EQ-5D-5L Domains According to Allergic Rhinitis and Asthma Control: A MASK-air Real-World Study

Bernardo Sousa-Pinto, Gilles Louis, Jorge Rodrigues, Antonio Francesco Maria Giuliano, Ilaria Baiardini, Fulvio Braido, Wienczyslawa Czarlewski, Anna Bedbrook, Tari Haahtela, Arunas Valiulis, Luisa Brussino, Lorenzo Cecchi, Alvaro A. Cruz, Bilun Gemicioglu, Wytske J. Fokkens, Juan Carlos Ivancevich, Ludger Klimek, Helga Kraxner, Piotr Kuna, Maciej KupczykVioleta Kvedariene, Désirée Larenas-Linnemann, Renaud Louis, Rachel Nadif, Marek Niedoszytko, Yoshitaka Okamoto, Markus Ollert, Nikolaos G. Papadopoulos, Vincenzo Patella, Ruby Pawankar, Nhân Pham-Thi, Oliver Pfaar, Frederico S. Regateiro, Nicolas Roche, Philip W. Rouadi, Boleslaw Samolinski, Joaquin Sastre, Marine Savouré, Nicola Scichilone, Aziz Sheikh, Luís Taborda-Barata, Sanna Toppila-Salmi, Arzu Yorgancioglu, Mihaela Zidarn, Josep M. Anto, Torsten Zuberbier, G. Walter Canonica, Maria Teresa Ventura, João A. Fonseca, Benoit Pétré, Jean Bousquet*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review


Background: EQ-5D-5L (EuroQOL, 5 Domains, 5 Levels) is a widely used health-related quality-of-life instrument, comprising 5 domains. However, it is not known how each domain is impacted by rhinitis or asthma control. Objective: To assess the association between rhinitis or asthma control and the different EQ-5D-5L domains using data from the MASK-air mHealth app. Methods: In this cross-sectional study, we assessed data from all MASK-air users (2015-2021; 24 countries). For the levels of each EQ-5D-5L domain, we assessed rhinitis and asthma visual analog scales (VASs) and the combined symptom-medication score (CSMS). We built ordinal multivariable models assessing the adjusted association between VAS/CSMS values and the levels of each EQ-5D-5L domain. Finally, we compared EQ-5D-5L data from users with rhinitis and self-reported asthma with data from users with rhinitis alone. Results: We assessed 5354 days from 3092 users. We observed an association between worse control of rhinitis or asthma (higher VASs and CSMS) and worse EQ-5D-5L levels. In multivariable models, all VASs and the CSMS were associated with higher levels of pain/discomfort and daily activities. For anxiety/depression, the association was mostly observed for rhinitis-related tools (VAS nose, VAS global, and CSMS), although the presence of self-reported asthma was also associated with worse anxiety/depression. Worse mobility (“walking around”) was particularly associated with VAS asthma and with the presence of asthma. Conclusions: A worse rhinitis control and a worse asthma control are associated with higher EQ-5D-5L levels, particularly regarding pain/discomfort and activity impairment. Worse rhinitis control is associated with worse anxiety/depression, and poor asthma control with worse mobility.

Original languageEnglish
JournalJournal of Allergy and Clinical Immunology: In Practice
Early online date10 Aug 2023
Publication statusE-pub ahead of print - 10 Aug 2023


  • Allergic rhinitis
  • Asthma
  • Mobile health
  • Quality of life


Dive into the research topics of 'Impairment of EQ-5D-5L Domains According to Allergic Rhinitis and Asthma Control: A MASK-air Real-World Study'. Together they form a unique fingerprint.

Cite this